Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$537M |
| 2 |
Peloton Interactive
PTON
|
+$373M |
| 3 |
Amazon
AMZN
|
+$306M |
| 4 |
S&P Global
SPGI
|
+$244M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$1.27B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$744M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$712M |
| 5 |
Pinduoduo
PDD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.2% |
| 2 | Technology | 16.96% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Communication Services | 11.19% |
| 5 | Consumer Staples | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
UBS Group
UBS
$176B
| $1.23M | ﹤0.01% |
86,700
-2,179,900
| -96% | -$28.9M |
|
|
MACK
2402
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.22M | ﹤0.01% |
+176,861
| New | +$872K |
|
2403
Nucor
NUE
$61.2B
| $1.21M | ﹤0.01% |
22,800
-195,900
| -90% | -$10.1M |
|
|
TAIT
2404
DELISTED
Taitron Components
TAIT
| $1.21M | ﹤0.01% |
372,974
+41,387
| +12% | +$111K |
|
2405
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
| $1.21M | ﹤0.01% |
23,200
+19,000
| +452% | +$956K |
|
2406
Super Micro Computer
SMCI
$25.7B
| $1.21M | ﹤0.01% |
+382,400
| New | +$1.08M |
|
|
FLNT
2407
Fluent
FLNT
$129M
| $1.21M | ﹤0.01% |
37,983
-7,784
| -17% | -$153K |
|
|
HALL
2408
DELISTED
Hallmark Financial Services, Inc.
HALL
| $1.21M | ﹤0.01% |
33,970
-4,940
| -13% | -$154K |
|
2409
BeyondSpring
BYSI
$34M
| $1.21M | ﹤0.01% |
98,838
+55,540
| +128% | +$730K |
|
|
DCBO
2410
Docebo
DCBO
$591M
| $1.21M | ﹤0.01% |
+18,600
| New | +$986K |
|
2411
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $1.2M | ﹤0.01% |
24,000
-2,000
| -8% | -$93K |
|
2412
Corbus Pharmaceuticals
CRBP
$197M
| $1.2M | ﹤0.01% |
32,070
+832
| +3% | +$31.1K |
|
2413
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
| $1.2M | ﹤0.01% |
10,100
+8,000
| +381% | +$896K |
|
|
XENT
2414
DELISTED
Intersect ENT, Inc
XENT
| $1.2M | ﹤0.01% |
52,315
+14,115
| +37% | +$269K |
|
|
INVX
2415
Innovex International
INVX
$2.19B
| $1.2M | ﹤0.01% |
40,400
+3,900
| +11% | +$111K |
|
2416
Tempest Therapeutics
TPST
$16.5M
| $1.19M | ﹤0.01% |
2,857
+113
| +4% | +$39.1K |
|
2417
Summit Therapeutics
SMMT
$10.7B
| $1.19M | ﹤0.01% |
253,212
-50,200
| -17% | -$213K |
|
2418
Amtech Systems
ASYS
$281M
| $1.18M | ﹤0.01% |
185,462
+36,600
| +25% | +$218K |
|
|
LUB
2419
DELISTED
Luby's Inc.
LUB
| $1.18M | ﹤0.01% |
414,852
-25,604
| -6% | -$72.2K |
|
|
PFIE
2420
DELISTED
Profire Energy, Inc
PFIE
| $1.18M | ﹤0.01% |
1,377,812
+26,500
| +2% | +$21.1K |
|
|
PSB
2421
DELISTED
PS Business Parks, Inc.
PSB
| $1.17M | ﹤0.01% |
8,800
-53,400
| -86% | -$6.87M |
|
2422
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.05B
| $1.17M | ﹤0.01% |
35,900
+12,800
| +55% | +$385K |
|
2423
AtriCure
ATRC
$2.25B
| $1.16M | ﹤0.01% |
20,900
-550,475
| -96% | -$23.8M |
|
|
MDP
2424
DELISTED
Meredith Corporation
MDP
| $1.16M | ﹤0.01% |
60,400
+25,600
| +74% | +$416K |
|
|
OPRA
2425
Opera Ltd
OPRA
$1.81B
| $1.16M | ﹤0.01% |
126,800
+114,900
| +966% | +$1.04M |
|
Similar funds
Jim Simons's Q4 2020 Portfolio in Review
As of Q4 2020, Jim Simons held 3,901 positions worth $92.1B, down 8% from $100B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons withdrew a net $21.6B in Q4 2020, closing 555 positions and reducing 1,622 holdings. Its most notable exit was Charter Communications, an estimated $341M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in NVIDIA worth $524M.
- Jim Simons's largest Q4 2020 buy was NVIDIA: 40,123,720 shares worth $524M.
- Jim Simons added most to Amazon in Q4 2020, an estimated $306M increase.
- Jim Simons's biggest Q4 2020 reduction was Zoom, cutting an estimated $1.27B.
- Jim Simons fully exited Charter Communications in Q4 2020, selling an estimated $341M.
- Jim Simons's ten largest holdings make up 13% of its $92.1B portfolio in Q4 2020.
- Jim Simons opened 565 new positions and closed 555 in Q4 2020.
- Jim Simons's portfolio value fell 8% quarter-over-quarter to $92.1B.
Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.